Co-Diagnostics
CODX49
$0.23arrow_drop_down2.32%-$0.00
Penny Stock
CODX49
$0.23
arrow_drop_down2.32%Performance History
| Key Stats | |
|---|---|
| Open | $0.24 |
| Prev. Close | $0.24 |
| EPS | -1.38 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $10.28M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.22 | 0.26 |
| 52 Week Range | 0.22 | 2.23 |
| Ratios | |
|---|---|
| EPS | -1.38 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Co-Diagnostics (CODX)
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Dwight H. Egan
- Headquarters
- Salt Lake City
- Employees
- 145
- Exchange
- NASDAQ
Keep an eye on Co-Diagnostics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Co-Diagnostics 's (CODX) price per share?
The current price per share for Co-Diagnostics (CODX) is $0.23. The stock has seen a price change of -$0.01 recently, indicating a -2.33% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Co-Diagnostics (CODX)?
For Co-Diagnostics (CODX), the 52-week high is $2.23, which is 852.99% from the current price. The 52-week low is $0.23, the current price is 2.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Co-Diagnostics (CODX) a growth stock?
Co-Diagnostics (CODX) has shown an average price growth of -1.65% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Co-Diagnostics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Co-Diagnostics (CODX) stock price performance year to date (YTD)?
As of the latest data, Co-Diagnostics (CODX) has a year-to-date price change of -68.8%. Over the past month, the stock has experienced a price change of -37.6%. Over the last three months, the change has been -61.69%. Over the past six months, the figure is -76.83%. Looking at a longer horizon, the five-year price change stands at -98.74%.
help
Is Co-Diagnostics (CODX) a profitable company?
Co-Diagnostics (CODX) has a net income of -$35.33M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 38.57% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.6K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6.81M, although specific revenue growth data is currently not available. The gross profit is $2.63M. Operating income is noted at -$42.71M. Furthermore, the EBITDA is -$38.67M.
help
What is the market capitalization of Co-Diagnostics (CODX)?
Co-Diagnostics (CODX) has a market capitalization of $10.29M. The average daily trading volume is 0.24, indicating the stock's liquidity and investor engagement.